Petros Pharmaceuticals Inc (PTPI) — Cash Flow-to-Debt Ratio
Petros Pharmaceuticals Inc (PTPI) has a Cash Flow-to-Debt Ratio of -0.05x as of March 2025, meaning its operating cash flow of $-1.49 Million could theoretically repay 0% of its total liabilities ($27.19 Million) in one year. See PTPI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Petros Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Petros Pharmaceuticals Inc across 7 annual periods. Also explore net asset momentum of Petros Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Petros Pharmaceuticals Inc (2018–2024)
Year-by-year debt coverage analysis for Petros Pharmaceuticals Inc. For market capitalisation and broader financial context, see PTPI company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.14x | $-2.60 Million | $18.10 Million | ▲ +59.8% |
| 2023 | -0.36x | $-7.63 Million | $21.32 Million | ▲ +56.1% |
| 2022 | -0.81x | $-12.80 Million | $15.72 Million | ▼ -118.6% |
| 2021 | -0.37x | $-11.86 Million | $31.85 Million | ▼ -27.5% |
| 2020 | -0.29x | $-15.31 Million | $52.38 Million | ▼ -680.9% |
| 2019 | 0.05x | $2.53 Million | $50.35 Million | ▼ -57.0% |
| 2018 | 0.12x | $8.02 Million | $68.57 Million | — |